BEVESPI AEROSPHERE: payments to doctors
Payments that named BEVESPI AEROSPHERE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $766K
- Providers
- 8,083
- Transactions
- 19,124
- Average per transaction
- $40
The per-transaction average — $40 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,083 providers the average total is $95, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $588,570 | 76.9% |
| Astrazeneca AB | $90,687 | 11.8% |
| Astrazeneca UK Limited | $86,366 | 11.3% |